A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


February 18, 2010

HIV Contributes to Lung Cancer Risk, but Not Nearly as Much as Smoking

by David Evans

HIV infection increases the risk of developing lung cancer by about 80 percent, according to a study presented Wednesday, February 17, at the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. However, it is smoking among people living with HIV that poses the greatest risk of developing lung cancer.

Researchers have long known that people with HIV are more likely to get certain cancers, such as Kaposi’s sarcoma, especially when their CD4 cell counts drop. They are called AIDS-related cancers (ARC), and the rates of these opportunistic illnesses have fallen dramatically since the introduction of combination antiretroviral (ARV) therapy in the late 1990s.

Other cancers, such as lung cancer, have not traditionally been associated with HIV, but studies conducted during the past couple of years have indicated that people with HIV might be at increased risk of developing such cancers, especially as they live longer and contend with other disease risk factors.

To determine whether HIV adds to the risk of developing lung cancer, Keith Sigel, MD, MPH, from Mount Sinai School of Medicine in New York City and his colleagues examined the medical records of people receiving care through veterans administration (VA) clinics and hospitals. So that accurate rates of smoking history could be factored into the study—previous studies on lung cancer in HIV have not controlled for this aspect very well—Sigel’s team focused on veterans who had also filled out a 1999 survey on tobacco use.

In all, Sigel and his colleagues narrowed down a database of more than 100,000 veterans to 3,707 HIV-positive and 9,980 HIV-negative participants. The median follow-up was eight years. Basic characteristics between the two groups were similar. The median age of both groups was 47; many were non-white and 98 percent were male. With respect to smoking, the two groups differed somewhat. HIV-positive participants were more likely to smoke currently or to have quit smoking only recently.

There were just over 200 diagnosis of lung cancer in both groups combined during the follow-up period.

Sigel’s team found that HIV itself, after factoring out other characteristics such as smoking and age, was associated with an increased risk for developing lung cancer—an 80 percent increase in the relative risk compared with HIV-negative participants. Yet the increased risk associated solely with HIV infection was modest compared with smoking history. Current smokers and people who had quit within the past year were almost 10 times as likely to develop lung cancer as people who’d never smoked. People who’d quit more than one year earlier were just over five times as likely to develop lung cancer. People who reported smoking only occasionally were about 3.5 times more likely to develop lung cancer.

Interestingly, Hispanic participants were less likely to develop lung cancer than white or black participants, and the author commented that this has been found in several other studies.

Sigel acknowledged that they were not able to determine whether ARVs influenced the development of lung cancer. The rates of some types of cancers decrease when ARV therapy increases CD4 cells and controls viral replication.

Sigel stated that segmenting people into groups (such as non-smokers, occasional smokers, recently quit smokers and smokers who’d quit less recently) has been validated in other studies to produce a good assessment of a person’s lung cancer risk. He said, however, that determining the actual quantities of cigarettes a person has smoked recently, or ever, would have given an even more detailed picture of smoking’s influence on lung cancer risk.

Search: smoking, lung cancer, risk, CROI

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.